Holographic Augmented Reality Versus Screen Visualisation of 3D Rendering Models for the Pre-operative Evaluation and Planning of Liver Resections
NCT ID: NCT06049836
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2023-10-15
2024-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Do the holographic models allow a superior accuracy in terms of anatomical evaluation and surgical planning?
* Is there any difference in terms of time consumed and Task Load Index? Participants will analyse cases through both modalities and answer a questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Augmented Reality in Minimally Invasive Surgery
NCT03678220
Damages From Macular Grasping During Vitrectomy Comparing Traditional and 3D Microscope
NCT05113212
Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope
NCT03075852
Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison
NCT04135638
Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
NCT01731964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Group A analyses 15 patient cases 3D Hologram models (first stage) and after the washout period the same 15 patients cases (anonymised, renamed and shuffled) in liver 3D models on computer monitor visualisation (PDF) (second stage)
Holograms
Clinical decision making based on visualising liver 3D holographic augmented reality liver models
Clinical decision making based on visualisation of 3D liver rendering on computer monitors on a PDF file
Group B
Group B analyses 15 patient cases liver 3D models on computer monitor visualisation (PDF) (first stage) and after the washout period the same 15 patients cases (anonymised, renamed and shuffled) on 3D Hologram models (second stage)
Holograms
Clinical decision making based on visualising liver 3D holographic augmented reality liver models
Clinical decision making based on visualisation of 3D liver rendering on computer monitors on a PDF file
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Holograms
Clinical decision making based on visualising liver 3D holographic augmented reality liver models
Clinical decision making based on visualisation of 3D liver rendering on computer monitors on a PDF file
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ICAR (Istituto di Calcolo e Reti ad Alte Prestazioni) - CNR (Consiglio Nazionale delle Ricerche)
UNKNOWN
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gianluca Rompianesi
Assistant Professor of Surgery - MD, PhD, FEBS (HPB, Transplantation)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto I Troisi, MD PhD FEBS
Role: PRINCIPAL_INVESTIGATOR
Federico II University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federico II University
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FIICNRHoloLiver
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.